Triple AAA SRL
3.0 FTEThe score of Triple AAA shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +7 % Total assets -26 % Headcount (avg FTE) +3 %
Accounts of the company itself (not consolidated).
The full file covers 8 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Triple AAA's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | −14,321 € | ||||
| Equity | 148,421 € | ||||
| Cash | 115,841 € | ||||
| EBITDA | 14,340 € | ||||
| Total assets | 532,534 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 03 Aug 2026
- Year ended 31 Dec 2024filed on 30 Jun 2025
- Year ended 31 Dec 2023filed on 28 Jun 2024
- Year ended 31 Dec 2022filed on 18 Jul 2023
- Year ended 31 Dec 2021filed on 07 Jun 2022
Triple AAA's financial analysis
- Solvency27.9%sector median: 37.8%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Triple AAA
Triple AAA's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0839.714.053
- VAT number
- BE0839714053
- Peppol
- Registered · 0208:0839714053 · as of 07 Nov 2026
- Legal form
- SRL
- Incorporated
- 28 Sep 2011
- Registered office
- 1140 Evere
- Size
- Micro · 3.0 FTE
- Latest accounts
- 2025 · filed on 03 Aug 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Triple AAA (SRL) has been based in Evere since 2011, active in: retail sale of pharmaceutical products. For 2025, it reports a net loss of 14,321 € and equity of 148,421 €; its revenue is not published. With 3.0 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 27.9%, below the median of its sector (37.8%).
Companies similar to Triple AAA
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie Mandragore Retail sale of pharmaceutical products Quaregnon · balance sheet 532,438 €
- Apotheek De Knop Retail sale of pharmaceutical products Meise · balance sheet 531,800 €
- Duran Zehra Retail sale of pharmaceutical products Ghent · balance sheet 531,335 €
- Pharma Stubbe Retail sale of pharmaceutical products Ingelmunster · balance sheet 535,694 €
- Farmapunt Maaseik Retail sale of pharmaceutical products Hamont-Achel · balance sheet 536,437 €
- LSRP Retail sale of pharmaceutical products Braives · balance sheet 527,233 €
- Rudophar Retail sale of pharmaceutical products Oostkamp · balance sheet 526,499 €
- Bankapotheek Retail sale of pharmaceutical products Antwerp · balance sheet 538,658 €
Frequently asked questions about Triple AAA
What is the revenue of Triple AAA?
Triple AAA files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Triple AAA?
In Belgium, the VAT number is the company number prefixed with BE: BE0839714053 for Triple AAA, if the company is VAT-registered. Its company number (CBE) is 0839.714.053.
Where is the registered office of Triple AAA?
According to the CBE register, the registered office of Triple AAA is in 1140 Evere.
What is the equity of Triple AAA?
At the close of the 2025 financial year, the equity of Triple AAA amounts to 148,421 €, a solvency of 27.9% of total assets.
How many people work at Triple AAA?
3.0 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Triple AAA?
The register lists 2 active mandates at Triple AAA. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Triple AAA
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →